Ferrokin Biosciences' Series B Round

Ferrokin Biosciences raised a round of funding on June 15, 2010.

FerroKin BioSciences is focused on the development of medicines used to manage iron for the treatment of disease. The company is currently developing a new treatment for transfusional iron overload. I…

Articles about Ferrokin Biosciences' Series B Round: